15888
CONCLUSION : Collectively , these findings demonstrate that BMY - 14802 provides anti - dyskinetic relief against L - DOPA and direct DA agonist in a preclinical model of PD , acting via multiple receptor systems and supports the utility of such compounds for the improved treatment of PD .
 Chemical: BMY - 14802; Chemical: L - DOPA
Please list all entity words in the text that fit the category.Output format is "type1: word1; type2: word2". 
Option: Chemical 
Text: {0} 
Answer:
 Chemical: BMY - 14802; Chemical: L - DOPA